Correlation Between Spyre Therapeutics and Amedica WT

Can any of the company-specific risk be diversified away by investing in both Spyre Therapeutics and Amedica WT at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spyre Therapeutics and Amedica WT into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Spyre Therapeutics and Amedica WT, you can compare the effects of market volatilities on Spyre Therapeutics and Amedica WT and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spyre Therapeutics with a short position of Amedica WT. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spyre Therapeutics and Amedica WT.

Diversification Opportunities for Spyre Therapeutics and Amedica WT

-0.21

Correlation Coefficient

Spyre Therapeutics  Amedica WT

Very good diversification

The 3 months correlation between Spyre and Amedica is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Spyre Therapeutics and Amedica WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amedica WT and Spyre Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spyre Therapeutics are associated (or correlated) with Amedica WT. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amedica WT has no effect on the direction of Spyre Therapeutics i.e., Spyre Therapeutics and Amedica WT go up and down completely randomly.

Pair Corralation between Spyre Therapeutics and Amedica WT

If you would invest  3,618  in Spyre Therapeutics on February 5, 2024 and sell it today you would lose (40.00) from holding Spyre Therapeutics or give up 1.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.55%
Values	Daily Returns

Spyre Therapeutics  vs.  Amedica WT

Spyre Therapeutics

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Spyre Therapeutics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Spyre Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Amedica WT

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Amedica WT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable fundamental indicators, Amedica WT is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Spyre Therapeutics and Amedica WT

The main advantage of trading using opposite Spyre Therapeutics and Amedica WT positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spyre Therapeutics position performs unexpectedly, Amedica WT can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedica WT will offset losses from the drop in Amedica WT's long position.

The idea behind Spyre Therapeutics and Amedica WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.